2024 Q2 Form 10-Q Financial Statement

#000072685424000135 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $75.99M $73.57M
YoY Change 12.28% 19.56%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.042M $1.072M $1.056M
YoY Change -8.52% -11.4% -18.27%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $21.37M $19.14M
YoY Change 75.42% 137.16%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $36.26M $36.66M $34.09M
YoY Change -10.72% 19.79% -9.08%
Income Tax $7.149M $7.132M $6.641M
% Of Pretax Income 19.71% 19.46% 19.48%
Net Earnings $28.86M $29.26M $27.20M
YoY Change -11.05% 20.22% -10.45%
Net Earnings / Revenue 37.97% 39.78%
Basic Earnings Per Share $1.96 $1.98
Diluted Earnings Per Share $1.96 $1.98 $1.84
COMMON SHARES
Basic Shares Outstanding 14.76M shares 14.82M shares 14.83M shares
Diluted Shares Outstanding 14.71M shares 14.82M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $218.0M $318.7M $156.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $71.04M $71.62M $72.15M
YoY Change -2.84% -2.46% 1.92%
Goodwill $149.9M
YoY Change 37.65%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $43.60M $43.97M $42.22M
YoY Change -7.12% 4.33% -5.94%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $6.341B $6.314B $6.168B
YoY Change 3.17% 1.66% 4.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $322.7M $304.9M $309.9M
YoY Change 18.75% 3.98% 6.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $322.7M $304.9M $309.9M
YoY Change 18.75% 3.98% 6.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $114.7M $121.2M $121.9M
YoY Change -7.39% -6.55% -12.59%
Total Long-Term Liabilities $114.7M $121.2M $121.9M
YoY Change -48.76% -6.55% -12.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $322.7M $304.9M $309.9M
Total Long-Term Liabilities $114.7M $121.2M $121.9M
Total Liabilities $5.655B $5.632B $5.491B
YoY Change 2.61% 1.3% 3.6%
SHAREHOLDERS EQUITY
Retained Earnings $817.5M $799.0M $780.3M
YoY Change 9.85% 10.71% 10.42%
Common Stock $222.5M $223.4M $47.62M
YoY Change -0.85% -0.79% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $230.9M $218.6M $217.7M
YoY Change 14.34% 21.8% 0.83%
Treasury Stock Shares
Shareholders Equity $686.7M $682.2M $677.1M
YoY Change
Total Liabilities & Shareholders Equity $6.341B $6.314B $6.168B
YoY Change 3.17% 1.66% 4.93%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $28.86M $29.26M $27.20M
YoY Change -11.05% 20.22% -10.45%
Depreciation, Depletion And Amortization $1.042M $1.072M $1.056M
YoY Change -8.52% -11.4% -18.27%
Cash From Operating Activities $28.32M $32.17M $33.58M
YoY Change 3.33% -19.38% -1.38%
INVESTING ACTIVITIES
Capital Expenditures $506.0K $596.0K $562.0K
YoY Change -54.46% -3.25% 21.12%
Acquisitions
YoY Change
Other Investing Activities -$132.8M $3.547M -$17.56M
YoY Change 545.7% -97.27% 25.41%
Cash From Investing Activities -$133.3M $2.951M -$18.12M
YoY Change 514.95% -97.72% 25.28%
FINANCING ACTIVITIES
Cash Dividend Paid $10.60M
YoY Change 10.52%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.290M $127.3M 30.22M
YoY Change -105.55% -291.58% -125.62%
NET CHANGE
Cash From Operating Activities 28.32M $32.17M 33.58M
Cash From Investing Activities -133.3M $2.951M -18.12M
Cash From Financing Activities 4.290M $127.3M 30.22M
Net Change In Cash -100.7M $162.4M 45.68M
YoY Change 40.78% 57.97% -146.44%
FREE CASH FLOW
Cash From Operating Activities $28.32M $32.17M $33.58M
Capital Expenditures $506.0K $596.0K $562.0K
Free Cash Flow $27.82M $31.57M $33.02M
YoY Change 5.77% -19.63% -1.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2024Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
12040000 usd
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
11773000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2023 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2024#AccountingStandardsUpdate202202Member
CY2024Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
830000 usd
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
1162000 usd
CY2024Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1570000 usd
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1591000 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
73568000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
61530000 usd
CY2024Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
14097000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
5690000 usd
CY2024Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
3621000 usd
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
2381000 usd
CY2024Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
1423000 usd
CY2023Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
0 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
19141000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
8071000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
54427000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
53459000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-180000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2918000 usd
CY2024Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
54607000 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
50541000 usd
CY2024Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-1000 usd
CY2023Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
773000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-152000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
361000 usd
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
927000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
804000 usd
CY2024Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
716000 usd
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
1326000 usd
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
17948000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
18682000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18878000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
17673000 usd
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
2840000 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2640000 usd
CY2024Q1 us-gaap Equipment Expense
EquipmentExpense
2929000 usd
CY2023Q1 us-gaap Equipment Expense
EquipmentExpense
3092000 usd
CY2024Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
711000 usd
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
445000 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
867000 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
760000 usd
CY2024Q1 chco Bankcard Expenses
BankcardExpenses
2039000 usd
CY2023Q1 chco Bankcard Expenses
BankcardExpenses
1509000 usd
CY2024Q1 us-gaap Postage Expense
PostageExpense
666000 usd
CY2023Q1 us-gaap Postage Expense
PostageExpense
647000 usd
CY2024Q1 us-gaap Supplies Expense
SuppliesExpense
453000 usd
CY2023Q1 us-gaap Supplies Expense
SuppliesExpense
420000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
482000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
470000 usd
CY2024Q1 us-gaap Communication
Communication
600000 usd
CY2023Q1 us-gaap Communication
Communication
606000 usd
CY2024Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-229000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-16000 usd
CY2024Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5645000 usd
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
5206000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
4700000 usd
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
35900000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
38623000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36655000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30600000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7132000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6259000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
24341000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.63
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
24341000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-14507000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
20634000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-1000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
773000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-14506000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
19861000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-3441000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
4762000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11065000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15099000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18458000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39440000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
577852000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
24341000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15099000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.65
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9485000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1093000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
218249 shares
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
20103000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
62078000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
651050000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
677066000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11065000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10798000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1100000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1309 shares
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
58000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
36438 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3653000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
682231000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
24341000 usd
CY2024Q1 chco Amortizationand Accretion Net
AmortizationandAccretionNet
1916000 usd
CY2023Q1 chco Amortizationand Accretion Net
AmortizationandAccretionNet
2302000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-180000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2918000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1072000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1210000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
984000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-654000 usd
CY2024Q1 us-gaap Pension Expense
PensionExpense
15000 usd
CY2023Q1 us-gaap Pension Expense
PensionExpense
13000 usd
CY2024Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-153000 usd
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
1134000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1100000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1093000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-42000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-102000 usd
CY2024Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
976000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
804000 usd
CY2024Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
3018000 usd
CY2023Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
2637000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
3035000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
2689000 usd
CY2024Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
17000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
52000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1469000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-759000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1364000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3156000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1376000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6599000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32168000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39901000 usd
CY2024Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-34018000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-6108000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49304000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
84940000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24201000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
26839000 usd
CY2024Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
9000 usd
CY2023Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
189000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
142000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
249000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
596000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
616000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
47000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
223000 usd
CY2023Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
206000 usd
CY2024Q1 chco Payments To Acquire Low Income Housing Tax Credits
PaymentsToAcquireLowIncomeHousingTaxCredits
5771000 usd
CY2023Q1 chco Payments To Acquire Low Income Housing Tax Credits
PaymentsToAcquireLowIncomeHousingTaxCredits
1704000 usd
CY2024Q1 chco Proceeds From Acquisition Of Business Gross
ProceedsFromAcquisitionOfBusinessGross
0 usd
CY2023Q1 chco Proceeds From Acquisition Of Business Gross
ProceedsFromAcquisitionOfBusinessGross
13518000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2951000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
129351000 usd
CY2024Q1 us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
16268000 usd
CY2023Q1 us-gaap Net Change Noninterest Bearing Deposits Domestic
NetChangeNoninterestBearingDepositsDomestic
9288000 usd
CY2024Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
105334000 usd
CY2023Q1 us-gaap Net Change Interest Bearing Deposits Domestic
NetChangeInterestBearingDepositsDomestic
-41622000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-29915000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-4208000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3653000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20103000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
58000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
202000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
203000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10603000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9594000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127287000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-66442000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
162406000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
102810000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156276000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
318682000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302810000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
17929000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
7694000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2510000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3500000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
700000 usd
CY2023Q1 chco Non Impaired Loans
NonImpairedLoans
246400000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
149902000 usd
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
149762000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1503572000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1585000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
157500000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1347657000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17108000 usd
CY2023Q1 chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
175000 usd
CY2023Q1 chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
2811000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
614000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
676000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1479545000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2870000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
144278000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1338137000 usd
CY2024Q1 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
23400000 usd
CY2024Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 usd
CY2023Q4 chco Non Governmental Issues Exceeding10 Shareholders Equity Threshold
NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold
0 usd
CY2024Q1 chco Non Governmental Issues Exceeding10 Shareholders Equity Threshold
NonGovernmentalIssuesExceeding10ShareholdersEquityThreshold
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
16713000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
8768000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
939870000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
148732000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
956583000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
157500000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
9637000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
10337000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
955196000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
133941000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
964833000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
144278000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses
0 usd
CY2023Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2630000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2598000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
108133000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
102535000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
406455000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
375247000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
986354000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
867277000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1503572000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1347657000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2918000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22724000 usd
CY2024Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1000000 usd
CY2024Q1 chco Threshold Periodfor Discontinuanceof Interest Accrual
ThresholdPeriodforDiscontinuanceofInterestAccrual
P90D
CY2024Q1 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
0 usd
CY2024Q1 chco Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
10786000 usd
CY2024Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0 usd
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
1000000 usd
CY2023Q4 chco Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
6558000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
84940000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
975000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
1000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
202000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-1000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
773000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
63000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
463000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
215000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
102000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-152000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
361000 usd
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
4091788000 usd
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
4125923000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22310000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22745000 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
4069478000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4103178000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22745000 usd
CY2024Q1 chco Impact Of Adopting Asu202202
ImpactOfAdoptingASU202202
0 usd
CY2024Q1 chco Citizens Purchased Credit Deteriorated Loan Reserves
CitizensPurchasedCreditDeterioratedLoanReserves
0 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
854000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
599000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-180000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22310000 usd
CY2023Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
270000 usd
CY2023Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 usd
CY2024Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 usd
CY2024Q1 chco Financing Receivable Collateral Dependent
FinancingReceivableCollateralDependent
0 usd
CY2023Q4 chco Financing Receivable Collateral Dependent
FinancingReceivableCollateralDependent
1000000 usd
CY2024Q1 us-gaap Financing Receivable Threshold Period Past Due
FinancingReceivableThresholdPeriodPastDue
P30D
CY2024Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
10786000 usd
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
4091788000 usd
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7558000 usd
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
4125923000 usd
CY2024Q1 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Amount
HedgedAssetFairValueHedgeLastOfLayerAmount
299200000 usd
CY2023Q4 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Amount
HedgedAssetFairValueHedgeLastOfLayerAmount
303700000 usd
CY2024Q1 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Cumulative Increase Decrease
HedgedAssetFairValueHedgeLastOfLayerCumulativeIncreaseDecrease
129000 usd
CY2023Q4 us-gaap Hedged Asset Fair Value Hedge Last Of Layer Cumulative Increase Decrease
HedgedAssetFairValueHedgeLastOfLayerCumulativeIncreaseDecrease
-20000 usd
CY2024Q1 us-gaap Fair Value Hedges At Fair Value Net
FairValueHedgesAtFairValueNet
1000000 usd
CY2024Q1 chco Fair Value Hedge Agreement Notional Amount
FairValueHedgeAgreementNotionalAmount
100000000 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
1673000 usd
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
1654000 usd
CY2024Q1 chco Interest And Fee Income Other Loans Cumulative Adjustment
InterestAndFeeIncomeOtherLoansCumulativeAdjustment
19000 usd
CY2024Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
129000 usd
CY2023Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
137000 usd
CY2024Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
207000 usd
CY2023Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
210000 usd
CY2024Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-93000 usd
CY2023Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-86000 usd
CY2024Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
15000 usd
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
13000 usd
CY2024Q1 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2023Q1 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2024Q1 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2023Q1 chco Combined Federal And State Income Tax Rate
CombinedFederalAndStateIncomeTaxRate
0.24
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-11066000 usd
CY2024Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11065000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
15687000 usd
CY2023Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
588000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15099000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
29523000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
24341000 usd
CY2024Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-261000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-214000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
29262000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24127000 usd
CY2024Q1 us-gaap Distributed Earnings
DistributedEarnings
10505000 usd
CY2023Q1 us-gaap Distributed Earnings
DistributedEarnings
9833000 usd
CY2024Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
18757000 usd
CY2023Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
14294000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
29262000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24127000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14795000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14818000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
26000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14819000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14844000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.63
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
0 usd
CY2024Q1 us-gaap Derivative Credit Risk Valuation Adjustment Derivative Assets
DerivativeCreditRiskValuationAdjustmentDerivativeAssets
0 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1871000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2459000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-22000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
95000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
0 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements
-683000 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1849000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
1871000 usd

Files In Submission

Name View Source Status
0000726854-24-000135-index-headers.html Edgar Link pending
0000726854-24-000135-index.html Edgar Link pending
0000726854-24-000135.txt Edgar Link pending
0000726854-24-000135-xbrl.zip Edgar Link pending
chco-20240331.htm Edgar Link pending
chco-20240331.xsd Edgar Link pending
chco-20240331_g1.jpg Edgar Link pending
exhibit31a03-31x2024.htm Edgar Link pending
exhibit31b03-31x2024.htm Edgar Link pending
exhibit32a03-31x2024.htm Edgar Link pending
exhibit32b03-31x2024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
chco-20240331_lab.xml Edgar Link unprocessable
chco-20240331_pre.xml Edgar Link unprocessable
chco-20240331_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
chco-20240331_def.xml Edgar Link unprocessable
chco-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable